Literature DB >> 27940296

Induction of type 1 iodothyronine deiodinase expression inhibits proliferation and migration of renal cancer cells.

Piotr Poplawski1, Beata Rybicka1, Joanna Boguslawska1, Katarzyna Rodzik1, Theo J Visser2, Alicja Nauman3, Agnieszka Piekielko-Witkowska4.   

Abstract

Type 1 iodothyronine deiodinase (DIO1) regulates peripheral metabolism of thyroid hormones that control cellular proliferation, differentiation and metabolism. The significance of DIO1 in cancer is unknown. In this study we hypothesized that diminished expression of DIO1, observed in renal cancer, contributes to the carcinogenic process in the kidney. Here, we demonstrate that ectopic expression of DIO1 in renal cancer cells changes the expression of genes controlling cell cycle, including cyclin E1 and E2F5, and results in inhibition of proliferation. The expression of genes encoding collagens (COL1A1, COL4A2, COL5A1), integrins (ITGA4, ITGA5, ITGB3) and transforming growth factor-β-induced (TGFBI) is significantly altered in renal cancer cells with induced expression of DIO1. Finally, we show that overexpression of DIO1 inhibits migration of renal cancer cells. In conclusion, we demonstrate for the first time that loss of DIO1 contributes to renal carcinogenesis and that its induced expression protects cells against cancerous proliferation and migration.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adhesion; Migration; Proliferation; Renal cancer; Type 1 iodothyronine deiodinase

Mesh:

Substances:

Year:  2016        PMID: 27940296     DOI: 10.1016/j.mce.2016.12.004

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

Review 1.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

2.  Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.

Authors:  Piotr Popławski; Jacek R Wiśniewski; Eddy Rijntjes; Keith Richards; Beata Rybicka; Josef Köhrle; Agnieszka Piekiełko-Witkowska
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

3.  Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis.

Authors:  Lea Landolt; Øystein Eikrem; Philipp Strauss; Andreas Scherer; David H Lovett; Christian Beisland; Kenneth Finne; Tarig Osman; Mohammad M Ibrahim; Gro Gausdal; Lavina Ahmed; James B Lorens; Jean Paul Thiery; Tuan Zea Tan; Miroslav Sekulic; Hans-Peter Marti
Journal:  Physiol Rep       Date:  2017-06

4.  COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS.

Authors:  Zheying Zhang; Cheng Fang; Yongxia Wang; Jinghang Zhang; Jian Yu; Yongxi Zhang; Xianwei Wang; Jiateng Zhong
Journal:  Int J Oncol       Date:  2018-08-22       Impact factor: 5.650

5.  LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.

Authors:  Yitong Zhang; Jiaxing Wang; Xiqing Liu
Journal:  Genes (Basel)       Date:  2020-04-17       Impact factor: 4.096

6.  COL1A1 promotes metastasis in colorectal cancer by regulating the WNT/PCP pathway.

Authors:  Zheying Zhang; Yongxia Wang; Jinghang Zhang; Jiateng Zhong; Rui Yang
Journal:  Mol Med Rep       Date:  2018-02-01       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.